POSTER SESSION IV & CONTINENTAL BREAKFAST

Wednesday, October 26, 2016: 7:30 AM - 9:00 AM
Bayshore Ballroom ABC, Lobby Level (Westin Bayshore Vancouver)
PS 4-1

DON'T KNOW RESPONDING TO RISK PERCEPTION MEASURES IN RELATION TO DEFENSIVE PROCESSES
Eva Janssen, PhD, Maastricht, Netherlands and Erika A. Waters, PhD, MPH, Washington University School of Medicine, Saint Louis, MO
PS 4-2

THE KITCHEN SINK: COMBINING MULTIPLE RISK COMMUNICATION STRATEGIES TO CONVEY MULTIPLE DISEASE RISKS
Eva Janssen, PhD, Maastricht, Netherlands and Erika A. Waters, PhD, MPH, Washington University School of Medicine, Saint Louis, MO
PS 4-3

SHARED DECISION-MAKING TRAINING TO PROMOTE EMPOWERMENT, RISK UNDERSTANDING AND QUESTION-ASKING: FINDINGS FROM A CLUSTER-RCT WITH LOWER LITERACY ADULTS
Danielle Muscat, BPsych(Hons)1, Suzanne Morony, PhD1, Heather Shepherd, PhD2, Sian Smith, PhD3, Haryana Dhillon, MA, PhD4, Lyndal Trevena, MBBS, MPhilPH, PhD1, Andrew Hayen, PhD5, Karen Luxford6, Don Nutbeam, PhD1 and Kirsten McCaffery, BSc, PhD1, (1)School of Public Health, University of Sydney, University of Sydney, Australia, (2)Psycho-oncology Co-operative Research Group, University of Sydney, University of Sydney, Australia, (3)Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia, (4)Centre for Medical Psychology & Evidence-based Decision-making (CeMPED), University of Sydney, Australia, (5)School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia, (6)Patient-based care, Clinical Excellence Commission, Sydney, Australia
PS 4-4

WEIGHING UP RISKS AND BENEFITS: BARRIERS AND FACILITATORS FOR HEALTH CONSUMERS WITH LOWER LITERACY
Danielle Muscat, BPsych(Hons)1, Suzanne Morony, PhD1, Heather Shepherd, PhD2, Sian Smith, PhD3, Haryana Dhillon, MA, PhD4, Lyndal Trevena, MBBS, MPhilPH, PhD1, Andrew Hayen, PhD5, Karen Luxford6, Don Nutbeam, PhD1 and Kirsten McCaffery, BSc, PhD1, (1)School of Public Health, University of Sydney, University of Sydney, Australia, (2)Psycho-oncology Co-operative Research Group, University of Sydney, University of Sydney, Australia, (3)Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia, (4)Centre for Medical Psychology & Evidence-based Decision-making (CeMPED), University of Sydney, Australia, (5)School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia, (6)Patient-based care, Clinical Excellence Commission, Sydney, Australia
PS 4-5

INTENSIVE CARE UNIT CLINICIANS' PERCEPTIONS OF PROGNOSTIC ACCURACY FEEDBACK
Kuldeep Yadav, BA1, Emily Pflug, BS2, Michael Josephs, BA3, Michael Detsky, MD, MSHP4, Scott Halpern, MD, PhD1 and Joanna Hart, MD, MSHP3, (1)Palliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania, Philadelphia, PA, (2)Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, (3)Fostering Improvements in End-of-Life Decision Science (FIELDS) Program, University of Pennsylvania, Philadelphia, PA, (4)Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
PS 4-7

DESIGNING DATA VISUALIZATIONS TO SUPPORT SHARED DECISION MAKING ABOUT BLOOD PRESSURE
Pete Wegier, PhD1, Jeffery L. Belden, MD1, Shannon M. Canfield, MPH1, Sonal J. Patil, MD1, Victoria A. Shaffer, PhD1, Linsey M. Steege, PhD2, Mihail Popescu, PhD1, KD Valentine, MS1, Akshay Jain, MS1, Andrew M. Hathaway, MA1, Michael L. LeFevre, MD MSPH1 and Richelle J. Koopman, MD MS1, (1)University of Missouri, Columbia, MO, (2)University of Wisconsin, Madison, WI
PS 4-8

PATIENTS OVERESTIMATE THEIR RISK, BUT THE MAGNITUDE DECREASES WHEN INFORMATION COMES FROM THEIR DOCTOR WITHOUT PATIENT'S OWN ESTIMATIONS
Shi-Yi Wang, MD, PhD1, Gabrielle Kelly, PhD2, Cary P. Gross, MD1 and Liana Fraenkel, MD, MPH3, (1)Yale Cancer Center, New Haven, CT, (2)Yale School of Public Health, New Haven, CT, (3)Yale University, West Haven, CT
PS 4-9

COMPARING PATIENT AND PROVIDER IDENTIFIED STRATEGIES TO IMPROVE COMMUNICATION ABOUT CHRONIC PAIN: WHAT'S SHARED DECISION MAKING GOT TO DO WITH IT?
Nananda F. Col, MD, MPH, MPP, FACP1, Stephen Hull, MD2, Vicky Springmann, MSc3, Mark Braun, MD, FACP4, Noah Nesin, MD5, Penney Cowan6, Samantha Shephard7, Lisa Marrache, MD8, Noel Geneva, MA, PA-C9, Rich Entel, MD10 and Edward Bilsky, PhD7, (1)Shared Decision Making Resources, Georgetown, ME, (2)Mercy Pain Center, Mercy Hospital, Portland, ME, (3)Tononto, ON, Canada, (4)Scarborough, ME, (5)Penobscot Community Health Care, Lincoln, ME, (6)American Chronic Pain Association, Rocklin, CA, (7)University of New England, Biddeford, ME, (8)VA Maine Healthcare System, Augusta, ME, (9)Portland Internal Medicine, Mercy Hospital/Eastern Maine Health Systems, Portland, ME, (10)Grace Street Services, Portland, ME
PS 4-10

IMPROVING ADHERENCE AMONG ADULT ASTHMATICS: IDENTIFYING A ROLE FOR ACTIVE PATIENT ENGAGEMENT
Samantha Pollard, MSc, University of British Columbia, Vancouver, BC, Canada, Nick Bansback, PhD, University of British Columbia; Centre for Clinical Epidemiology and Evaluation; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, J Mark FitzGerald, MD, FACP., UBC , Department of Medicine,The Lung Centre, Vancouver, BC, Canada and Stirling Bryan, PhD, University of British Columbia; Centre for Clinical Epidemiology & Evaluation, Vancouver, BC, Canada
PS 4-11

CONTRACEPTIVE RISK PERCEPTION: LESSONS LEARNED FROM AN INNOVATIVE SHARED DECISION MODULE
Aparna Sridhar, MD MPH1, Christopher S. Saigal, MD, MPH2, Meghana Munnangi1, Karmjit Sagoo1 and Sylvia Lambrechts, MPH MA1, (1)David Geffen School of Medicine at UCLA, Los Angeles, CA, (2)David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA
PS 4-12

MISPERCEPTION OF TRANSPLANT LISTING STATUS AMONG HEMODIALYSIS PATIENTS
Amar Bansal, MD, Vanessa Madden, B.Sc., Brian Bayes, MS, Nicole Gabler, PhD, MHA, MPH, Peter Reese, MD, MSCE, Scott Halpern, MD, PhD and Katherine Courtright, MD, MS, University of Pennsylvania, Philadelphia, PA
PS 4-13

EVALUATING SHARED DECISION-MAKING IN TRIAL OF LABOR AFTER CESAREAN COUNSELING USING OBJECTIVE STRUCTURED CLINICAL EXAMINATIONS
Brownsyne Tucker Edmonds, MD, MPH, MS1, Fatima McKenzie, MS1, MacKenzie Austgen1, Janet Panoch, MA2, Abigail Litwiller, MD3 and Mark Di Corcia, PhD4, (1)Indiana University School of Medicine, Indianapolis, IN, (2)IU School of Medicine, Indianapolis, IN, (3)University of Illinois at Chicago, Chicago, IL, (4)Florida Atlantic University, Boca Raton, FL
PS 4-14

PARENTS' PERSPECTIVES ON ANTENATAL DECISION MAKING FOR THE ANTICIPATED BIRTH OF A PERIVIABLE INFANT
Brownsyne Tucker Edmonds, MD, MPH, MS, Indiana University School of Medicine, Indianapolis, IN, Teresa Savage, PhD, RN, University of Illinois at Chicago College of Nursing, Chicago, IL, Robert Kimura, MD, Rush Medical College, Chicago, IL, Sarah Kilpatrick, MD, PhD, 4Cedars-Sinai Medical Center, Los Angeles, CA, Miriam Kuppermann, PhD, MPH, University of California, San Francisco, Department of Obstetrics, Gynecology & Reproductive Sciences, San Francisco, CA, William Grobman, MD, MBA, Northwestern University Feinberg School of Medicine, Chicago, IL and Karen Kavanaugh, PhD, RN, FAAN, Wayne State University College of Nursing, Detroit, MI
PS 4-15

SHARED DECISION MAKING WITH MULTIPLE STAKEHOLDERS: IN VITRO FERTILIZATION AND EMBRYO TRANSFER
Elizabeth Duthie, PhD1, Alexandra Cooper, PhD2, Joseph Davis, DO3, Jay Sandlow, MD1, Katherine Schoyer, MD1, Estil Strawn, MD1 and Kathryn Flynn, PhD1, (1)Medical College of Wisconsin, Milwaukee, WI, (2)Duke University, Durham, NC, (3)Michigan State University, The Fertility Center, Grand Rapids, MI
PS 4-16

EXPLORING WHY PATIENTS DO NOT PURSUE INFERTILITY TREATMENT AFTER MEETING WITH A REPRODUCTIVE SPECIALIST
Alexandra Cooper, PhD1, Elizabeth Duthie, PhD2, Joseph Davis, DO3, Jay Sandlow, MD2, Katherine Schoyer, MD2, Estil Strawn, MD2 and Kathryn Flynn, PhD2, (1)Duke University, Durham, NC, (2)Medical College of Wisconsin, Milwaukee, WI, (3)Michigan State University, The Fertility Center, Grand Rapids, MI
PS 4-17

FIRST IMPRESSIONS: “WHAT DO YOU THINK OF WHEN YOU HEAR THE WORDS SIDE EFFECT?”
Sonya Izadi, BA1, Courtney Wheeler, MPH1, Jaclyn McGuire, MPH1, Thorsten Pachur, PhD2 and Erika A. Waters, PhD, MPH1, (1)Washington University School of Medicine, Saint Louis, MO, (2)Max Planck Institute for Human Development, Berlin, Germany
PS 4-18

ENGAGING THE CANADIAN PUBLIC ON REIMBURSEMENT DECISION-MAKING FOR DRUGS FOR RARE DISEASES: A NATIONAL ONLINE SURVEY
Julie Polisena, Ottawa, ON, Canada, Michael Burgess, PhD, The University of British Columbia, Kelowna, BC, Canada, Craig Mitton, Vancouver, ON, Canada and Larry Lynd, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
PS 4-19

UNDERSTANDING ATTITUDES ABOUT ADVANCE CARE PLANNING AND INFORMATION NEEDS IN PATIENTS WITH CYSTIC FIBROSIS AND THEIR CAREGIVERS
Melissa Basile, PhD1, Johanna Andrews, MPH1, Denis Hadjiliadis, MD2, Janice Wang, MD3 and Negin Hajizadeh, MD, MPH4, (1)Northwell Health, Manhasset, NY, (2)University of Pennsylvania School of Medicine, Philadelphia, PA, (3)Northwell Health, Lake Success, NY, (4)Hofstra Northwell LIJ School of Medicine, Manhasset, NY
PS 4-20

NUDGING AND/OR BOOSTING? AN INQUIRY ON THE ETHICAL JUSTIFICATION OF NORMS FOR MODELING AND IMPLEMENTATION OF EVIDENCE-BASED POLICY AND CLINICAL PRACTICE FOR PATIENT ENGAGEMENT
Luciana S. Garbayo, MD, PhD, University of Central Florida, Orlando, FL, Elisabeth Giesenhagen, PhD, German Institute for Medical Documentation and Information (DIMDI), Cologne, Germany and James Stahl, Massachusetts General Hospital, MGH-ITA, Boston, MA
PS 4-21

PATIENT CENTERED CARE FOR GERIATRIC PATIENTS: INFORMATION EXPERT PROVIDERS USE TO MAKE PATIENT CENTERED CARE DECISIONS
Jorie Butler, PhD, Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, UT, Bryan Gibson, PhD, SLC VA IDEAS Center of Innovation, Salt Lake City, UT, Tania Velasquez, MA, Salt Lake City VA, SALT LAKE CITY, UT and Charlene Weir, PhD, Department of Biomedical Informatics, School of Medicine, University of Utah, Salt Lake City, UT
PS 4-22

VALUE OF PERFECT IMPLEMENTATION: INCREASING ADHERENCE TO CHOLESTEROL LOWERING THERAPIES
Torbjørn Wisløff, Norwegian Institute of Public Health, Oslo, Norway and Ivar Sønbø Kristiansen, MD, PhD, MPH, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway
PS 4-23

DEMENTIA AS A COMORBIDITY OF DIABETES IN EVALUATING THE DIABETES PREVENTION PROGRAMME
Penny Breeze, PhD, Sheffield, United Kingdom, Praveen Thokala, PhD, University of Sheffield, Sheffield, United Kingdom and Alan Brennan, MSc, PhD, Health Economics and Decision Science (HEDS), School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom
PS 4-24

IMMEDIATE COLECTOMY VERSUS ENHANCED SURVEILLANCE FOR LOW-GRADE DYSPLASIA IN ULCERATIVE COLITIS
Elliot Arsoniadis, MD, University of Minnesota, Minneapolis, MN and Karen M. Kuntz, ScD, University of Minnesota School of Public Health, Minneapolis, MN
PS 4-25

EFFECTIVENESS OF MULTIDISCIPLINARY CARE FOR PATIENTS WITH DIABETES IN MEXICO: AN APPLICATION OF QUASI-EXPERIMENTAL METHODS
David Contreras-Loya, MSc1, Fernando Alarid-Escudero, MS, PhD Candidate2 and S.G. Sosa-Rubí, PhD1, (1)Instituto Nacional de Salud Publica, Cuernavaca, Mexico, (2)Division of Health Policy and Management, University of Minnesota, Minneapolis, MN
PS 4-26

UTILIZING NUTRITION RISK SCREENING TO TACKLE 30-DAY UNPLANNED READMISSIONS AND LENGTH OF STAY AMONG HOSPITALIZED ADULT PATIENTS
Suela Sulo, PhD1, Wm. Thomas Summerfelt, PhD2, Jamie Partridge, PhD1, Gretchen VanDerBosch, RD2, Maureen Dziadosz, RN2, Refaat Hegazi, MD PhD1 and Krishnan Sriram, MD2, (1)Abbott Nutrition, Columbus, OH, (2)Advocate Health Care, Downers Grove, IL
PS 4-27

FACTORS AFFECTING HEALTH-RELATED QUALITY OF LIFE IN TYPE 1 DIABETES PATIENTS IN IRELAND
Adam Raymakers, MSc, Mary Clare O'Hara, Matthew Griffin, MD, Sean Dinneen, MD and Paddy Gillespie, PhD, National University of Ireland, Galway, Ireland
PS 4-28

AGING WELL AND VALUED PURPOSES: DOES MULTI-MORBIDITY HAVE AN IMPACT?
Dominik Ose, PhD, MPH1, Michael F. Scheier, PhD2, Karen Matthews, PhD3, Joyce Chung-Chou H. Chang, PhD4, Stacey Dillon, MS, MA5, Doris M. Rubio, PhD6 and Rachel Hess, MD, MS1, (1)University of Utah, Department of Population Health Sciences, Division of Health System Innovation and Research, Salt Lake City, UT, (2)Carnegie Mellon University, Department of Psychology, Pittsburgh, PA, (3)University of Pittsburgh, Department of Psychiatry, Pittsburgh, PA, (4)University of Pittsburgh, Division of General Internal Medicine, Pittsburgh, PA, (5)University of Pittsburgh, Center for Research on Healthcare, Pittsburgh, PA, (6)University of Pittsburgh, Center for Research on Health Care, Pittsburgh, PA
PS 4-29

EVALUATION OF THE IMPACT OF COMORBIDITIES AND PRE-EXISTING CONDITIONS ON SEPSIS PRESENTATION
Muge Capan, PhD1, Nisha Nataraj, PhD Student2, Liana Lin, PhD Student2, Min Chi, PhD2, Julie Ivy, PhD2 and Ryan Arnold, MD1, (1)Christiana Care Health System, Newark, DE, (2)North Carolina State University, Raleigh, NC
PS 4-30

EXAMINING THE IMPACT OF INTRACRANIAL HEMORRHAGE RELATIVE TO ISCHEMIC STROKE IN ANTICOAGULATED PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
Matthew Pappas, MD, MPH, University of Michigan Health System, Ann Arbor, MI, Sandeep Vijan, MD, MS, Ann Arbor VA Medical Center; University of Michigan Health System, Ann Arbor, MI, Michael Rothberg, MD, MPH, Cleveland Clinic, Cleveland, OH and Daniel Singer, MD, Massachusetts General Hospital, Boston, MA
PS 4-31

ESTIMATING THE COMPARATIVE EFFECTIVENESS OF LONGITUDINAL INTERVENTIONS
Noemi Kreif, PhD1, Richard Grieve, PhD1, Bianca DeStavola1, Robert Tasker, MB, BS, MD2, Maya Petersen, MD, PhD3 and Linh Tran, PhD4, (1)London School of Hygiene and Tropical Medicine, London, United Kingdom, (2)Boston Children's Hospital, Boston, MD, (3)UC Berkeley, Berkeley, CA, (4)Berkeley, CA
PS 4-32

MAKING DECISIONS UNDER UNCERTAINTY: THE VALUE OF ECONOMIC EVALUATIONS IN THE ASSESSMENT OF NON-DRUG HEALTH TECHNOLOGIES IN CANADA
Bernice Tsoi, BSc, MSc, PhD and Karen M. Lee, MA, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada
PS 4-34

WHAT CAUSES RACIAL DISPARITIES IN HEALTH CARE? A MIXED-METHODS STUDY OF PROVIDERS NEGOTIATING UNCERTAINTY IN ATTRIBUTING BLAME AND RESPONSIBILITY
Sarah Gollust, PhD1, Brooke Cunningham, MD, PhD1, Barbara Bokhour2, Howard Gordon, MD3, Charlene Pope, PhD4, Somnath Saha5, Dina Jones, MPH6, Tam Do, BA7 and Diana Burgess, PhD7, (1)University of Minnesota, Minneapolis, MN, (2)Department of Health Law, Policy & Management; Boston University School of Public Health, Boston, MA, (3)Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL, (4)College of Nursing, Medical University of South Carolina, Charleston, SC, (5)VA Portland Health Care System, Portland, OR, (6)Tobacco Center of Regulatory Science (TCORS), School of Public Health, Georgia State University, Atlanta, GA, (7)Minneapolis VAHCS Center for Chronic Disease Outcomes Research, Minneapolis, MN
PS 4-36

SUPPORTING POLICY DECISIONS UNDER UNCERTAINTY USING POPULATION MODELS – A SYSTEMATIC REVIEW
Beate Jahn, PhD1, Annette Conrads-Frank, PhD1, Gaby Sroczynski, MPH, Dr.PH1, Ursula Rochau, MD, MSc2, Günther Zauner, PhD3, Marvin Bundo, MD1, Michael Gyimesi4, Gottfried Endel, Dr.5, Niki Popper, MSc6 and Uwe Siebert, MD, MPH, MSc, ScD7, (1)Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (2)UMIT, Hall i.T., Austria, (3)dwh GmbH, simulation services / DEXHELPP (Decision Support for Health Policy and Planning), Vienna, Austria, (4)Austrian Public Health Institute, Vienna, Austria, (5)Department for Evidence Based Economic Health Care, Main Association of Austrian Social Insurance Institutions, Vienna, Austria, (6)Institute for Analysis and Scientific Computing, Technical University Vienna/ DEXHELPP, Vienna, Austria, (7)UMIT, Dept. of Public Health, Health Services Research & HTA / Harvard Univ., Dept. Health Policy & Management, Institute for Technology Assessment / Oncotyrol - Center for Personalized Cancer Medicine, Hall in Tirol (Austria) / Boston (USA), Austria
PS 4-37

IS VERY EARLY HTA POSSIBLE? A MATHEMATICAL FRAMEWORK OF USING ECONOMIC EVALUATION MODELS TO INFLUENCE THE DIRECTION OF DRUG DISCOVERY
William W. L. Wong, PhD, School of Pharmacy, University of Waterloo, Kitchener, ON, Canada
PS 4-38

SYSTEMATIC OVERVIEW OF RESPONSE CRITERIA AMONG PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Igor Stojkov, MPharm1, Ursula Rochau, MD, MSc2, Helena Borba, MPharm3, Milica Jevdjevic, DMD1, Karin Koinig, Dr4, Marjan Arvandi, MS5, Fabio Efficace, Dr6, Reinhard Stauder, Dr4 and Uwe Siebert, MD, MPH, MSc, ScD7, (1)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, Hall i. T., Austria, (2)UMIT, Dept. of Public Health, Health Services Research & HTA / ONCOTYROL - Center for Personalized Cancer Medicine, Area 4 HTA and Bioinformatics, Hall i. T./Innsbruck, Austria, (3)Department of Pharmacy, Pharmaceutical Sciences Postgraduate Research Program, Federal University of Parana, Curitiba, Brazil, (4)Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria, (5)Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (6)Health Outcomes Research Unit, Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA), Rome, Italy, (7)UMIT, Dept. of Public Health, Health Services Research & HTA / Harvard Univ., Dept. Health Policy & Management, Institute for Technology Assessment / Oncotyrol - Center for Personalized Cancer Medicine, Hall in Tirol (Austria) / Boston (USA), Austria
PS 4-40

APPROACH TO EVIDENCE-BASED OPERATIONAL MODELING OF A HIGH-VOLUME SURGICAL HOSPITAL
Abigail Schmucker, BA1, Mayu Sasaki, MPH1, Scott DeNegre, PhD2, Eileen Finerty, RN2, Steven Magid, MD1 and Nathaniel Hupert, MD, MPH3, (1)Quality Research Center, Hospital for Special Surgery, New York, NY, (2)Hospital for Special Surgery, New York, NY, (3)Weill Medical College, Cornell University, New York, NY
PS 4-41

RELIABILITY AND CONSISTENCY OF THREE VALUE FRAMEWORKS FOR ONCOLOGY THERAPEUTICS
Tanya G.K. Bentley, PhD1, Joshua T. Cohen, PhD2, Elena B. Elkin, PhD3, Julie Huynh, MD4, Arnab Mukherjea, DrPH, MPH5, Thanh H. Neville, MD, MSHS6, Ioana Popescu, MD, MPH7, Jenelle M. Zambrano, DNP, CNS, RN1, Eunice Chang, PhD1 and Michael S. Broder, MD, MSHS1, (1)Partnership for Health Analytic Research, LLC, Beverly Hills, CA, (2)Tufts Medical Center, Boston, MA, (3)Memorial Sloan-Kettering Cancer Center, New York, NY, (4)Hematology Oncology Medical Group of San Fernando Valley, Encino, CA, (5)California State University, East Bay, Hayward, CA, (6)UCLA Department of Medicine, Los Angeles, CA, (7)David Geffen School of Medicine at UCLA, Department of Medicine, Los Angeles, CA
PS 4-42

EMPIRICAL ESTIMATION OF OVERDIAGNOSIS IN TRIALS AND POPULATION STUDIES
Roman Gulati, MS1, Eric Feuer, PhD2 and Ruth Etzioni, PhD1, (1)Fred Hutchinson Cancer Research Center, Seattle, WA, (2)National Cancer Institute, Bethesda, MD
PS 4-43

EFFICIENCY OF VIRTUAL RECRUITMENT METHODS FOR BROAD AND SPECIFIC STUDY POPULATIONS
Shefali Kumar, MPH, Leslie Oley, MS and Jessie Juusola, PhD, Evidation Health, San Mateo, CA
PS 4-44

BEST PRACTICES AND RESEARCH NEEDS IN QUALITY MEASUREMENT: FEEDBACK FROM QUALITATIVE INTERVIEWS WITH MEASUREMENT EXPERTS
Alexandra Dalton, PhD1, Carmen L. Lewis, MD, MPH1, Bennett Parnes, MD2, Douglas Fernald, MA2 and Corey Lyon, DO3, (1)University of Colorado School of Medicine, Aurora, CO, (2)University of Colorado Anschutz School of Medicine, Department of Family Medicine, Aurora, CO, (3)University of Colorado Anschutz School of Medicine, Department of Family Medicine, Denver, CO
PS 4-45

HOW WELL WERE HEART FAILURE CLINICAL TRIAL ENDPOINTS SELECTED? EVIDENCE FROM A REVIEW OF CLINICALTRIALS.GOV AND OBSERVATIONAL STUDIES
Meng Li, ScM1, Jordan Banks2, Kelley Branch2, Josh Carlson, MPH, PhD1, David Veenstra, PharmD, PhD1 and Anirban Basu, PhD1, (1)Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, (2)Seattle, WA
PS 4-46

HOW DO CHILDREN AND PARENTS WANT TO BE INVOLVED IN MAKING DECISIONS FOR CHILD ANXIETY AND DEPRESSION TREATMENT?: A QUALITATIVE STUDY
David Langer, Ph.D.1, Lydia Chevalier, M.A.1, Alex Keller, M.A.1, Annie Dantowitz, L.C.S.W.1, Tessa Mooney, M.A.1, Celia E. Wills, PhD, RN2 and Lawrence Palinkas, Ph.D.3, (1)Boston University, Boston, MA, (2)The Ohio State University, Columbus, OH, (3)University of Southern California, Los Angeles, CA
PS 4-47

EVALUATING THE VALIDITY OF PARENTAL REPORTS OF HEALTHCARE UTILIZATION FOR CHILDREN WITH SUSPECTED GENETIC DISORDERS OF UNKNOWN CAUSE
Nick Dragojlovic1, Ellen Kim1, Alison M. Elliott2, Jan M. Friedman2, Causes Study Group2 and Larry D. Lynd, PhD1, (1)Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, (2)Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
PS 4-48

DEPRESSION MANAGEMENT USING ELECTRONIC HEALTH RECORD: PERSONALIZED PROGRESSION PREDICTION AND MONITORING
Weiwei Shang, MS, University of Washington, Seattle, WA and Shan Liu, PhD, Industrial and Systems Engineering, University of Washington, Seattle, WA
PS 4-49

DATA-DRIVEN ANALYSIS OF MINED ELECTRONIC HEALTH RECORDS REVEALS ASSOCIATIONS BETWEEN INTIMATE PARTNER VIOLENCE AND ADVERSE HEALTH CONSEQUENCES
Larry Liu1, Kate Whiting2, Mehmet Koyuturk3 and Gunnur Karakurt2, (1)Case Western Reserve University - Center for Proteomics and Bioinformatics, Cleveland, OH, (2)Case Western Reserve University - Department of Psychiatry, UH Mood Disorders Program, Cleveland, OH, (3)Case Western Reserve University - Department of Electrical Engineering and Computer Science, Cleveland, OH
PS 4-50

TRAUMA CENTER BASED ELECTRONIC INJURY SURVEILLANCE: IMPLICATIONS FOR PRECISION PUBLIC HEALTH
Larissa Roux, MD MPH PhD1, S. Morad Hameed, MD MPH2, Nadine Schuurman, PhD3, Damon Ramsey, MD4, RT Spence, MD, MPH5, Andrew John Nicol, MBChB, PhD6, Alan Hubbard, PhD7, Mitchell Jay Cohen, MD, FACS8, Rachel Callcut, MD, MSPH9 and Richard Matzopoulous, BBusSci, MPhil (Epidemiology), PhD (Public Health)6, (1)T6 Health Systems, Vancouver, BC, Canada, (2)T6 Health Systems, Chestnut Hill, MA, (3)Simon Fraser University, Burnaby, BC, Canada, (4)InputHealth, Vancouver, BC, Canada, (5)University of Cape Town Health Sciences Faculty, Cape Town, South Africa, (6)University of Cape Town, Cape Town, South Africa, (7)University of California at Berkeley, Berkeley, CA, (8)University of Colorado Department of Surgery, Denver, CO, (9)UCSF, San Francisco, CA
PS 4-52

HOW MUCH IS IT WORTH TO PREVENT SHINGLES? USING COST-EFFECTIVENESS ANALYSIS TO DETERMINE VALUE-BASED PRICING OF A NEW HERPES ZOSTER VACCINE
Phuc Le, PhD, MPH, Medicine Institute Cleveland Clinic, Cleveland, OH and Michael Rothberg, MD, MPH, Cleveland Clinic, Cleveland, OH
PS 4-53

IS HIGH-DOSE INFLUENZA VACCINE COST-EFFECTIVE IN HIGH-RISK NONELDERLY PATIENTS?
Kenneth J. Smith, MD, MS1, Jonathan M Raviotta, MPH2, Shawn T Brown3, Jay DePasse3, Eunha Shim4, Mary Patricia Nowalk2 and Richard K Zimmerman, MD, MPH, MA5, (1)University of Pittsburgh, Section of Decision Sciences, Pittsburgh, PA, (2)University of Pittsburgh, Pittsburgh, PA, (3)Pittsburgh Supercomputing Center, Carnegie Mellon University, Pittsburgh, PA, (4)Soongsil University, Seoul, Korea, Republic of (South), (5)University of Pittsburgh, School of Medicine, Dept of Family Medicine, Pittsburgh, PA
PS 4-54

COST-EFFECTIVENESS OF THE 4 PILLARS IMMUNIZATION TOOLKIT TO INCREASE VACCINATION RATES IN ADULT ELDERS
Kenneth J. Smith, MD, MS1, Chyongchiou J Lin2, Mary Patricia Nowalk2 and Richard K Zimmerman, MD, MPH, MA3, (1)University of Pittsburgh, Section of Decision Sciences, Pittsburgh, PA, (2)University of Pittsburgh, Pittsburgh, PA, (3)University of Pittsburgh, School of Medicine, Dept of Family Medicine, Pittsburgh, PA
PS 4-55

THE COST STRUCTURE OF ROUTINE IMMUNIZATION SERVICES: RESULTS FROM SIX COUNTRIES
Fangli Geng, MS1, Christian Suharlim, MPH MD1, Zachary J. Ward, MPH1, Logan Brenzel2, Stephen C. Resch, MPH PHD1 and Nicolas Menzies, PhD1, (1)Center for Health Decision Science - Harvard T.H. Chan School of Public Health, Boston, MA, (2)Bill & Melinda Gates Foundation, Washington, DC
PS 4-56

PREGNANT WOMEN'S DECISION-MAKING REGARDING INFLUENZA VACCINATION IN BRITISH COLUMBIA
Devon Greyson, PhD, MLIS and Julie Bettinger, PhD, MPH, Vaccine Evaluation Center, University of British Columbia, Vancouver, BC, Canada
PS 4-57

COMPARATIVE EFFECTIVENESS OF INACTIVATED AND LIVE-ATTENUATED INFLUENZA VACCINE IN CHILDREN: A DECISION-ANALYTIC MODEL
Evan Sorley, MS1, Maria Sundaram, MSPH1, Szu-Yu Zoe Kao, MA2, Yang Liu, MS1 and Fernando Alarid-Escudero, MS, PhD Candidate2, (1)Division of Environmental Health Sciences, University of Minnesota, Minneapolis, MN, (2)Division of Health Policy and Management, University of Minnesota, Minneapolis, MN
PS 4-58

PREFERENCES FOR HEALTH ECONOMICS PRESENTATIONS AMONG VACCINE POLICY MAKERS AND RESEARCHERS
John S. Richardson, MPH, University of Michigan, Ann Arbor, MI, Lisa A. Prosser, MS, PhD, University of Michigan, Child Health Evaluation and Research Center, Ann Arbor, MI and Mark L. Messonnier, MS PhD, Centers for Disease Control and Prevention, Atlanta, GA
PS 4-59

THE ECONOMIC BURDEN OF RHEUMATOID ARTHRITIS: BEYOND HEALTH CARE COSTS
Wei Zhang, PhD1, Stanley Wong1, Daphne Guh1, Huiying Sun, PhD2, Diane Lacaille, MD, MHSc, FRCPC3 and Aslam H. Anis, PhD4, (1)Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, (2)CIHR Canadian HIV Trials Network, Vancouver, BC, Canada, (3)Department of Medicine, University of British Columbia, Richmond, BC, Canada, (4)University of British Columbia, Vancouver, BC, Canada
PS 4-60

POINT OF CARE DATA COLLECTION AND ANALYTICS IN TRAUMA SURGERY
S. Morad Hameed, MD MPH1, Larissa Roux, MD MPH PhD2, Alan Hubbard, PhD3, Rachel Callcut, MD, MSPH4, Maureen Brennan, CHIM, CAISS, PMP5, Hubert Bandurski1, Igor Muravyov1, Lew Cohen1 and Mitchell Jay Cohen, MD, FACS6, (1)T6 Health Systems, Chestnut Hill, MA, (2)T6 Health Systems, Vancouver, BC, Canada, (3)University of California at Berkeley, Berkeley, CA, (4)UCSF, San Francisco, CA, (5)Vancouver, BC, Canada, (6)University of Colorado Department of Surgery, Denver, CO
See more of: 38th Annual North American Meeting of the Society for Medical Decision Making
<< Previous Session | Next Session >>